...
首页> 外文期刊>AIChE Journal >Integrated batch-to-batch and nonlinear model predictive control for polymorphic transformation in pharmaceutical crystallization
【24h】

Integrated batch-to-batch and nonlinear model predictive control for polymorphic transformation in pharmaceutical crystallization

机译:药品结晶中多态转化的批次间和非线性模型预测集成控制

获取原文
获取原文并翻译 | 示例

摘要

Polymorphism, a phenomenon in which a substance can have more than one crystal form, is a frequently encountered phenomenon in pharmaceutical compounds. Different polymorphs can have very different physical properties such as crystal shape, solubility, hardness, color, melting point, and chemical reactivity, so that it is important to ensure consistent production of the desired polymorph. In this study, an integrated batch-to-batch and nonlinear model predictive control (B2B-NMPC) strategy based on a hybrid model is developed for the polymorphic transformation of L-glutamic acid from the metastable -form to the stable β-form crystals. The hybrid model comprising of a nominal first-principles model and a correction factor based on an updated PLS model is used to predict the process variables and final product quality. At each sampling instance during a batch, extended predictive self-adaptive control (EPSAC) is employed as a NMPC technique to calculate the control action by using the current hybrid model as a predictor. At the end of the batch, the PLS model is updated by utilizing the measurements from the batch and the above procedure is repeated to obtain new control actions for the next batch. In a simulation study using a previously reported model for a polymorphic crystallization with experimentally determined parameters, the proposed B2B-NMPC control strategy produces better performance, where it satisfies all the state constraints and produces faster and smoother convergence, than the standard batch-to-batch strategy. ? 2010 American Institute of Chemical Engineers AIChE J, 2011
机译:多态性是一种物质可以具有不止一种晶型的现象,是药物化合物中经常遇到的现象。不同的多晶型物可以具有非常不同的物理性质,例如晶体形状,溶解度,硬度,颜色,熔点和化学反应性,因此确保所需多晶型物的稳定生产非常重要。在这项研究中,开发了基于混合模型的批次间和非线性模型预测集成控制策略(B2B-NMPC),用于将L-谷氨酸从亚稳型转变为稳定的β型晶体。包含名义第一原理模型和基于更新的PLS模型的校正因子的混合模型用于预测过程变量和最终产品质量。在批处理期间的每个采样时刻,扩展的预测自适应控制(EPSAC)被用作NMPC技术,以通过使用当前的混合模型作为预测器来计算控制动作。在批次结束时,通过利用来自批次的测量值来更新PLS模型,并重复上述过程以获得下一个批次的新控制动作。在使用先前报告的模型通过实验确定的参数进行多晶结晶的模拟研究中,提出的B2B-NMPC控制策略具有更好的性能,可以满足所有状态约束条件,并且比标准的批量生产具有更快更平滑的收敛性。批处理策略。 ? 2010美国化学工程师学会AIChE J,2011

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号